However, a recent study failed no correlation between body mass index and IL-17 expression in 95 patients with depression (85) and secukinumab-induced skin remission in patients with Ps does not reduce body weight after 12 or 24 weeks of treatment (86). The gene discussed is IL17A; the disease is major depressive disorder.